★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ PharmaceuticalsLabor, Education & Demographics Obesity Drug Market to Remain Heavily Concentrated Among Two Firms, Hefty US Price Tags Dominate Sales Popular GLP-1 agonists from Novo Nordisk and Eli Lilly are projected to retain a combined 80% market share among weight…McAlinden Research PartnersFebruary 20, 2024
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ PharmaceuticalsMarkets FTC Settles Suit Over Amgen-Horizon Deal, Potentially Averting Further Pharma M&A Hurdles The FTC's settlement with Amgen and Horizon has cleared the way for the two companies to complete a $27.8 billion…McAlinden Research PartnersSeptember 5, 2023
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ PharmaceuticalsMarkets Johnson & Johnson Faces Patent Hurdles in Drug Business, Potentially Setting the Tone for Pharma Peers Johnson & Johnson's most recent earnings data showed revenues and earnings per share growing more robustly than analysts anticipated. However,…McAlinden Research PartnersApril 18, 2023
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareFinanceⓁ PharmaceuticalsMarkets Pfizer’s M&A Strategy Sketches Roadmap for Pharma to Rebuild Pipelines, Overcome Patent Cliffs Pfizer's acquisition of Seagen, which is the largest biopharma deal since 2019, comes as products received in previous deals begin…McAlinden Research PartnersMarch 14, 2023
★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareMarkets AI Promises to Accelerate Drug Discovery, Streamline Biotech Breakthroughs AI is transforming industries across every sector of the economy. Biotech and pharma are now experiencing a boom in AI initiatives…McAlinden Research PartnersJuly 27, 2021
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & Healthcare Opioid Defendants Manage to Delay Trial, but Settlement Plans Slipping Away As the massive 2700-case litigation against major producers and distributors of opioids continues in Ohio, many lawyers and Attorneys General…McAlinden Research PartnersOctober 23, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Landmark Opioid Suit Sets Dangerous Precedent for Big Pharma In two back-to-back blockbuster headlines, Johnson & Johnson was found liable for damages related to the US opioid crisis and…McAlinden Research PartnersAugust 28, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Drugmaker Difficulties Piling Up From Courtrooms, Congress, and China As litigation against some of the world’s foremost drugmakers finally enters the courtroom, some companies have already settled a number…McAlinden Research PartnersJune 25, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Major Drugmakers Face Declining Sales, New Disruptors, and Democrat-Led Regulations At first glance, first quarter earnings for the pharmaceutical sector appear to be largely positive, with only a few nuggets…McAlinden Research PartnersMay 1, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Pending Legislation, Slower Price Inflation and Rising Competition Boost MRP’s Short Pharma Theme Investors seeking a more defensive positioning have rushed into health care stocks in recent months, as hype about the aging…McAlinden Research PartnersFebruary 4, 2019